Genetic polymorphisms of long noncoding RNA RP11-37B2.1 associate with susceptibility of tuberculosis and adverse events of antituberculosis drugs in west China.
Jiajia SongTangyuheng LiuZhenzhen ZhaoXuejiao HuQian WuWu PengXuerong ChenBinwu YingPublished in: Journal of clinical laboratory analysis (2019)
Our findings firstly exhibit that rs218916 and rs160441 within lncRNA RP11-37B2.1 significantly associate with the occurrence of thrombocytopenia and suggest RP11-37B2.1 genetic variants are potential biosignatures for thrombocytopenia during anti-TB treatment.